Delivery Order SPE2DB20D1109-SPE2DB22FN10P
Award Date 11/22/21
Potential Completion Date 11/23/21
Potential Value $4.3K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $2,178.60, is for the delivery of Buprenorphine 20 MCG/HR Patch 4S, a pharmaceutical product, to support military and government healthcare programs. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026....
- This federal contract award, valued at $5,384.93, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Buprenorphine 15 MCG/HR Patch 4S, a medication used for pain management. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical division. This single-award IDC serves as the primary...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Buprenorphine 20 MCG/HR Patch 4S. The $1,946.84 firm fixed-price contract has a completion date of June 21, 2023 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract...
- This federal contract award is for the delivery of Buprenorphine 10 MCG/HR Patch 4S, a medication used for pain management. The contract, valued at $1,968.62, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order placed under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen's parent company, Cencora, Inc., and the Defense Logistics Agency (DLA) Troop Support Medical, valued at up...
- This federal contract award is for the delivery of Buprenorphine 15 MCG/HR Patch 4S, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,162.20 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on February 19, 2025, with a period of performance through February 20, 2025. The contract is a Delivery Order issued under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award, with the ID SPE2DX15D1104|SPE2DX24F3EF5, was granted to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,138.43 firm fixed-price delivery order is for the supply of 4 units of a 20 mcg/hr buprenorphine patch, a specialized pharmaceutical product. The award is not designated under any set-aside program. It is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the...
- This federal contract award, with ID SPE2DX15D2213|SPE2DX24F7X9X, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,562,954,459 units of Buprenorphine 20 mcg/hr Patches. The award has a ceiling value of $1,056.00 and an ultimate completion date of December 1, 2023. This is a delivery order contract with a firm fixed price pricing type. The contract is not set aside for any...
- This federal contract award is for the delivery of Buprenorphine 15 MCG/HR Patch 4S, a pain management medication, to the Defense Logistics Agency (DLA). The $2,422.28 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on November 1, 2021, with a completion date of November 2, 2021. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc.,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Buprenorphine 15 micrograms per hour transdermal patches in a quantity of four units, with a total ceiling value of $1,120.96. This firm fixed-price delivery order is scheduled for completion by November 5, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was made without a set-aside designation, indicating open competitive...
- This federal contract award SPE2DB20D1109|SPE2DB23FP08V was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,255.16 firm fixed-price delivery order is for the supply of 4560861778 BUPRENORPHINE 10 MCG/HR PATCH 4S, a medication used for pain management. The contract has an ultimate completion date of May 9, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract...